ProQR Therapeutics NV (NASDAQ:PRQR)

1.73
Delayed Data
As of Dec 01
 +0.18 / +11.61%
Today’s Change
1.11
Today|||52-Week Range
3.85
-53.24%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for ProQR Therapeutics NV have a median target of 4.07, with a high estimate of 6.11 and a low estimate of 1.84. The median estimate represents a +135.50% increase from the last price of 1.73.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in ProQR Therapeutics NV. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.02
Sales
$16.6M
Reporting Date
Feb 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 129.85%
 
 
 
 
 
 
Growthannually 67.17%
 
 
 
 
 
 

Sales

Growthquarterly 1,109.55%
 
 
 
 
 
 
Growthannually 402.08%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.